Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1600 AUD | +3.23% |
|
+3.23% | -5.88% |
03/07 | Elanco Animal Health Enters Into Licensing Agreement With Neurizon for Monepantel | MT |
02/07 | Neurizon Therapeutics Secures License Deal With Animal Health Company; Shares Up 3% | MT |
Main competitors
Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
- | - | - | - | - | - | - | 4.98Cr | ||
0.76% | 0.85% | 36.6x | 26.41x | 12.1x | 27.59x | 29.71x | 70TCr | ||
3.36% | 3.45% | 14.92x | 5.07x | 4.16x | 11.46x | 12.73x | 37TCr | ||
3.46% | 3.62% | 26.89x | 46.52x | 6.51x | 13.55x | 13.97x | 34TCr | ||
2.93% | 3.41% | 17.26x | 9.94x | 6.23x | 12.42x | 13.72x | 31TCr | ||
3.83% | 3.92% | 14.15x | 5.33x | 3.48x | 8.64x | 9.89x | 26TCr | ||
3.21% | 3.36% | 17.35x | 5.19x | 4.7x | 11.39x | 12.32x | 24TCr | ||
2.29% | 2.41% | 22.25x | 4.83x | 4.13x | 12.18x | 12.92x | 22TCr | ||
3.95% | 4.15% | 10.43x | 3.7x | 3.38x | 7.3x | 8.12x | 20TCr | ||
3.23% | 3.39% | 22.59x | 17.68x | 5.81x | 11.27x | 13.16x | 16TCr | ||
6.67% | 6.8% | 12.11x | 1.6x | 2.94x | 7.3x | 8.45x | 15TCr | ||
2.93% | 3.06% | 20.4x | 6.12x | 5.21x | 9.52x | 11.49x | 14TCr | ||
-.--% | -.--% | 31.02x | 6.06x | 9.23x | 19.42x | 20.38x | 12TCr | ||
4.97% | 5.24% | 11.67x | 1.29x | 2.42x | 7.91x | 8.63x | 12TCr | ||
5.27% | 5.45% | 10.48x | 4.62x | 2.78x | 7.31x | 7.7x | 9.57TCr | ||
4.6% | 4.9% | 9.91x | 3.89x | 2.19x | 6.49x | 7.43x | 7.76TCr | ||
3.65% | 1.72% | 26.06x | 5.67x | 8.66x | 17.04x | 17.82x | 7.74TCr | ||
0.43% | 0.5% | 46.77x | 6.37x | 10.2x | 37.36x | 40.77x | 4.94TCr | ||
4.55% | 4.64% | 28.22x | 1.01x | 2.35x | 8.66x | 21.83x | 4.73TCr | ||
Average | 3.34% | 3.38% | 21.06x | 8.96x | 5.36x | 13.16x | 15.06x | 19.33TCr | |
Weighted average by Cap. | 2.94% | 3.06% | 22.08x | 13.56x | 6.25x | 14.52x | 15.96x |
- Stock Market
- Equities
- NUZ Stock
- Sector Neurizon Therapeutics Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition